Introducing a New Era in Bone Health Management
The collaboration aims to provide innovative fracture liaison services through an AI-driven navigator designed for post-fracture care.
The partnership between the American Orthopaedic Association's Own the Bone program and RevelAi Health marks a significant advancement in managing osteoporosis. This initiative seeks to close critical gaps in care for patients with fractures while aligning with new value-based healthcare regulations.
Addressing the Osteoporosis Challenge
Every year, many individuals suffer from osteoporosis-related fractures, a substantial public health concern. In the U.S., approximately 1.5 million fractures occur annually due to this condition, highlighting the urgent need for effective post-fracture management. Notably, hip fractures lead to around 300,000 cases annually, posing serious risks to patients' independence and health. The mortality rate within a year for those with hip fractures is alarmingly high at 20-25%. Unfortunately, less than a third of affected individuals go on to receive appropriate osteoporosis treatment; moreover, an overwhelming 80% of patients do not obtain guideline-directed bone care.
AI-Enhanced Patient Care
As the landscape of healthcare evolves, the focus on hip fractures is intensifying due to CMS' new Transforming Episode Accountability Model (TEAM). Starting soon, selected hospitals will be held accountable for both the costs and quality of care they provide in treating these high-cost procedures. This shift emphasizes the growing necessity for intelligent AI solutions to enhance bone health services, ensuring they meet rigorous reporting standards without overburdening healthcare providers.
What the AI-Powered Navigator Offers
The collaboration between Own the Bone and RevelAi will establish a unique bone health navigator tailored for healthcare professionals and care teams. Built using Own the Bone's established protocols and registry expertise, this AI-driven tool is designed to be integrated seamlessly into clinical workflows, assisting in various aspects of patient management:
- The navigator features a conversational interface providing instant access to evidence-based guidelines and best practices, ensuring that healthcare providers can deliver consistent care at the point of service.
- It aids in developing operational workflows such as managing fracture liaison services and optimizing prior-authorization processes and coding accuracy.
- The system supports tracking of patient outcomes, osteoporosis treatment progress, and tasks related to registry reporting and TEAM compliance.
- Resource integration is also a key feature, granting access to patient education materials aligned with clinician guidance, thus promoting informed decision-making for patients and families.
Dr. Christian Pean, an orthopedic trauma surgeon at Duke University School of Medicine and CEO of RevelAi Health, remarked on the collaboration's significance. He stated, "The Own the Bone program has set the standard for post-fracture osteoporosis care in the United States for over a decade. With the shift towards a mandatory episode-based treatment model, it's crucial that teams are equipped with more than just static tools; they require an intuitive AI navigator to assist them in real-time, ultimately ensuring that high-risk patients receive the necessary treatments."
Dr. Kyle Jeray, President of the AOA, echoed this sentiment, emphasizing that "Own the Bone has always focused on empowering orthopedic teams with the necessary resources to improve patient outcomes. This initiative represents a substantial leap forward in the efforts to prevent secondary fractures and enhance bone health management among orthopedic patients." Dr. Kevin Kirk, chair of the Own the Bone Steering Committee, also expressed enthusiasm about utilizing RevelAi's technology to streamline bone health management, stating that it "provides our teams with real-time support to ensure adherence to evidence-based practices, driving better patient care."
The first deployment of this AI navigator is anticipated to begin in coordination with select Own the Bone sites. This initial rollout targets established fracture liaison services within leading health systems and high-volume private practices, with plans for wider availability across various treatment centers in the future.
About Own the Bone
Founded in 1887, the American Orthopaedic Association (AOA) enjoys recognition as the oldest orthopaedic organization worldwide. The AOA's Own the Bone program serves as a crucial national initiative aimed at improving hospitals' post-fracture care pathways for bone health. By providing clinicians with educational resources, registry tools, and evidence-based measures, the initiative actively works to identify and manage patients at risk of osteoporosis and related fractures. Hospitals participating in the program have demonstrated significant enhancements in both treatment protocols and patient counseling.
About RevelAi Health
RevelAi Health specializes in using AI to enhance care coordination and documentation, specifically within the musculoskeletal domain. By collaborating with orthopedic professionals and AI developers, their platform offers unique solutions designed to navigate complex care challenges, including managing high-risk episodes such as hip fractures, while supporting value-based care initiatives like the CMS TEAM model.
Frequently Asked Questions
What is the purpose of the AI-powered bone health navigator?
The navigator is designed to assist care teams in managing osteoporosis and fractures more effectively by providing real-time, evidence-based guidance within their workflows.
How does this partnership enhance bone health care?
This partnership integrates innovative AI technology to streamline clinical processes, ensuring patients receive timely and appropriate treatment while helping healthcare providers meet new value-based care requirements.
Who are the key players in this collaboration?
The collaboration involves the American Orthopaedic Association's Own the Bone program and RevelAi Health, both committed to improving bone health management through advanced technology.
What is the expected outcome of using the AI navigator?
By employing the AI navigator, healthcare teams aim to improve patient outcomes, enhance the quality of care, and reduce operational burdens associated with fracture management.
When will the AI navigator be available for use?
Early access deployment is planned for 2026 at select sites, with a broader rollout anticipated thereafter.
